SCHEMBL5007928

SCHEMBL5007928

CC(CCNC(=O)c1cc2ccccc2s1)CC(=O)N1CCN(C(=O)CNS(=O)(=O)c2ccc(Cl)cc2Cl)[C@@H](C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.49
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
ACKR3 P25106 1/20 0.39
CCR1 P32246 1/20 0.39
DRD3 P35462 6/20 0.39
DRD2 P14416 6/20 0.39
HTR1A P08908 3/20 0.39
HTR2A P28223 3/20 0.39
OPRM1 P35372 3/20 0.37
DRD1 P21728 2/20 0.36
CCR8 P51685 1/20 0.36
RAB9A P51151 1/20 0.36
DRD4 P21917 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
HTR2B P41595 1/20 0.36
NPY5R Q15761 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5004473 0.92 TRPV4 (0.54) TRPV4SLC6A2SLC6A4ACKR3CCR1
SCHEMBL5007972 0.85 TRPV4 (0.54) TRPV4SLC6A2SLC6A4ACKR3DRD3
SCHEMBL13996613 0.85 TRPV4 (0.56) TRPV4CCR1OPRM1CCR8NPY5R
SCHEMBL4972801 0.84 TRPV4 (0.69) TRPV4ACKR3CCR1CCR8
SCHEMBL5007939 0.83 TRPV4 (0.60) TRPV4SLC6A2SLC6A4ACKR3CCR1
SCHEMBL8010445 0.82 TRPV4 (0.68) TRPV4ACKR3CCR1CCR8
SCHEMBL4972317 0.82 TRPV4 (0.68) TRPV4ACKR3CCR1CCR8
SCHEMBL5004501 0.81 TRPV4 (0.72) TRPV4SLC6A2SLC6A4ACKR3CCR1
SCHEMBL5007925 0.81 TRPV4 (0.58) TRPV4SLC6A2SLC6A4ACKR3CCR1
SCHEMBL5004470 0.81 TRPV4 (0.57) TRPV4SLC6A2SLC6A4ACKR3CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318945-A1 Novel Compounds CASILLAS LINDA N 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318945-A1 Novel Compounds TRPV4, TRPV1, TRPV3 TRPV4 1/4885SLC6A2 1372/4885SLC6A4 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.